openPR Logo
Press release

2022 Osteoporosis Drugs Market Complete Analysis & Global Prognostications

01-17-2018 02:48 PM CET | Health & Medicine

Press release from: Market Research Future

2022 Osteoporosis Drugs Market Complete Analysis & Global

The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%.
Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.
The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.
The market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.
The market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2479

The report for Global Osteoporosis Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market-2479
Key Players for Global Osteoporosis Drugs Market:
Some of the key players in this market are: Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical Industries Ltd. and others.
Segments:
Global osteoporosis drugs market has been segmented on the basis of drug class which comprises bisphosphonates, calcitonin’s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.
Regional Analysis of Global Osteoporosis Drugs Market:
Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2479
Study Objectives Global Osteoporosis Drugs Market:- To provide detail analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global osteoporosis drugs market, To provide insights about factors affecting the market growth. To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. To provide country level analysis of the market with respect to the current market size and future prospective. To provide country level analysis of the market for segments by drug class (bisphosphonates, calcitonins, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others), by route of administration (oral, injectable and others) and by gender (male, female and children). To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.
Continue…
We are thankful for the support and assistance from Global Osteoporosis Drugs Market Research Report - Forecast to 2022 chain related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: Sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2022 Osteoporosis Drugs Market Complete Analysis & Global Prognostications here

News-ID: 905195 • Views:

More Releases from Market Research Future

1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and Forecast to 2032
1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and F …
1-Hexene, a key chemical intermediate primarily used in the production of polyethylene, is experiencing a significant surge in demand globally. This demand is driven by several factors, including the growing need for high-density polyethylene (HDPE) and linear low-density polyethylene (LLDPE) in various industries such as packaging, construction, and automotive. The 1 Hexene Market is estimated at US$ 0.142 billion in 2024 and is forecasted to increase rapidly at a CAGR of
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a CAGR of 9.40% during the forecast period 2032
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a …
Hydroxypropyl Methylcellulose (HPMC) capsules are a popular choice in the pharmaceutical and nutraceutical industries due to their versatility, safety, and stability. These capsules are derived from cellulose, a natural polymer, and are widely used for encapsulating a variety of drugs, supplements, and vitamins. The HPMC capsules market has been experiencing steady growth over the years, driven by several key factors. Hydroxypropyl Methylcellulose Capsules Market was valued at USD 0.420 Billion in
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
The Skincare Market was valued at USD 7.15 Billion in 2022. It is forecasted to increase from USD 7.54 Billion in 2023 to USD 11.58 Billion by 2032, demonstrating a compound annual growth rate (CAGR) of 5.51% between 2023 and 2032. The comprehensive scope and research methodology of the Skincare Market report lay the foundation for a detailed and insightful analysis of the industry. The report's scope encompasses a broad spectrum,
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Share, Future Growth, Forecast Research Report 2032 
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Sh …
The wire and cable material market is a vital sector of the global economy, serving as the backbone for various industries, including telecommunications, energy, automotive, and construction. The market encompasses a wide range of materials used in the production of wires and cables, such as copper, aluminum, polymers, and insulating materials. Over the years, the market has witnessed significant evolution driven by technological advancements, regulatory changes, and shifting consumer preferences. The

All 5 Releases


More Releases for Osteoporosis

Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022 The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%. Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews February 03, 2017 Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related